Related Experiment Video
Updated: Apr 30, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Tenosynovial giant cell tumors lacking giant cells: report of diagnostic pitfalls
Yi Ding1, Jennifer E Griffin, Meera Raghavan
1Director of Analytic Microscopy Core, Director of Cytopathology Fellowship Program, Associate Member/Professor, Departments of Anatomic Pathology, Sarcoma and Chemical Biology and Molecular Medicine Program, Moffitt Cancer Center, Departments of Oncological Sciences, Cell Biology and Pathology, Morsani College of Medicine at University of South Florida, 12902 Magnolia Dr., Tampa, FL 33612, USA; phone: 813 745 4940; fax: 813 745 5970; e mail: Marilyn. bui@moffitt.org.
Abstract:
Tenosynovial giant cell tumors are a group of neoplastic disorders that involve synovium-lined tendon sheaths, synovial joints, and adjacent soft tissue. They are divided into localized and diffuse subtypes. TSGCTs have well-established clinical and histological diagnostic criteria; however, the subtypes and nomenclature can be confusing. They also pose diagnostic challenges when they occur in atypical locations or without multinucleated giant cells. With the possibility for systemic targeted therapy in relapsing pigmented villonodular tenosynovitis and diffuse-type giant cell tumor, accurate diagnosis and subtyping of TSGCTs is increasingly important. We report two cases of TSGCTs in order to elucidate the diagnostic nomenclature, clinicopathological features, differential diagnosis, and diagnostic pitfalls. Recent advancements in the pathogenesis and targeted therapy of TSGCTs are also discussed.